Enablex - darifenacin
Navigation: NDC > Supplier starting with: N > NOVARTIS PHARMACEUTICALS CORPORATION| Field | Value |
|---|---|
| NDC Code: | 0078-0419 |
| Proprietary Name: | Enablex |
| Suffix: | |
| Non-Proprietary Name: | darifenacin |
| Dosage Form: | TABLET, EXTENDED RELEASE |
| Method: | ORAL |
| Original Marketing Date: | 22-12-2004 |
| End of Marketing: | 30-06-2014 |
| Category Name: | NDA |
| Application Number: | NDA021513 |
| Labeler: | NOVARTIS PHARMACEUTICALS CORPORATION |
| Substance Name: | DARIFENACIN |
| Active Numerator Strength: | 7.5 |
| Active Ingredient Unit: | mg/1 |
| Pharm Classes: | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |
| DEA Schedule: |